台股 » 個股 » 杏國 » 籌碼相關 » 券商分點績效

杏國

(4192)
  • 股價
    44.20
  • 漲跌
    ▲0.10
  • 漲幅
    +0.23%
  • 成交量
    3
  • 產業
    上櫃 生技醫療類股
  • 120人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
杏國 (4192)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/25     後一日»

券商獲利排行 - 2024/04/25

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  7.24%10.3010.3-30347.7047.744.2
  7.53%7.207.2-20247.8047.844.2
  6.36%606-20247.2047.244.2
  7.53%3.603.6-10147.8047.844.2
  7.53%3.603.6-10147.8047.844.2
  7.53%3.603.6-10147.8047.844.2
  6.46%303-10147.3047.344.2
  6.36%303-10147.2047.244.2
  5.78%2.702.7-10146.9046.944.2
   00000047.8047.844.2
   00000047.847.8044.2
   00000046.146.1044.2
   0000004646044.2
   00000047.847.8044.2
   0000004646044.2
   00000047.847.8044.2
  -6.36%-30-311047.247.2044.2
  -6.36%-30-311047.247.2044.2
  -6.36%-30-311047.247.2044.2
  -6.46%-30-311047.347.3044.2
  -6.65%-3.10-3.111047.447.4044.2
  -7.53%-3.60-3.611047.847.8044.2
  -3.77%-3.60-3.612147.847.847.844.2
  -7.53%-3.60-3.611047.847.8044.2
  -7.53%-3.60-3.611047.847.8044.2
  -7.53%-3.60-3.611047.847.8044.2
  -7.14%-10.20-10.233047.647.6044.2

券商虧損排行 - 2024/04/25

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -7.14%-10.20-10.233047.647.6044.2
  -3.77%-3.60-3.612147.847.847.844.2
  -7.53%-3.60-3.611047.847.8044.2
  -7.53%-3.60-3.611047.847.8044.2
  -7.53%-3.60-3.611047.847.8044.2
  -7.53%-3.60-3.611047.847.8044.2
  -6.65%-3.10-3.111047.447.4044.2
  -6.46%-30-311047.347.3044.2
  -6.36%-30-311047.247.2044.2
  -6.36%-30-311047.247.2044.2
  -6.36%-30-311047.247.2044.2
   0000004646044.2
   00000047.847.8044.2
   00000047.847.8044.2
   0000004646044.2
   00000047.8047.844.2
   00000047.847.8044.2
   00000046.146.1044.2
  5.78%2.702.7-10146.9046.944.2
  6.36%303-10147.2047.244.2
  6.46%303-10147.3047.344.2
  7.53%3.603.6-10147.8047.844.2
  7.53%3.603.6-10147.8047.844.2
  7.53%3.603.6-10147.8047.844.2
  6.36%606-20247.2047.244.2
  7.53%7.207.2-20247.8047.844.2
  7.24%10.3010.3-30347.7047.744.2
杏國將在歐洲腫瘤內科學會亞洲年會 發表胰臟癌臨床結果UDN聯合新聞網-2022/09/25
杏國胰臟癌新藥三期試驗喊卡 待美FDA通知補件Anue鉅亨-2022/05/18
杏國 相關文章